TY  - GEN
AU  - Rouëssé,Jacques
AU  - de la Lande,Brigitte
AU  - Bertheault-Cvitkovic,Frédérique
AU  - Serin,Daniel
AU  - Graïc,Yvon
AU  - Combe,Martin
AU  - Leduc,Bernard
AU  - Lucas,Virginie
AU  - Demange,Liliane
AU  - Nguyen,Tan Dat
AU  - Castèra,Daniel
AU  - Krzisch,Claude
AU  - Villet,Richard
AU  - Mouret-Fourme,Emmanuelle
AU  - Garbay,Jean-Rémy
AU  - Noguès,Catherine
TI  - A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results
SN  - 0360-3016
PY  - 2006///0420
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Chemotherapy, Adjuvant
KW  - Confidence Intervals
KW  - Cyclophosphamide
KW  - administration & dosage
KW  - Disease-Free Survival
KW  - Drug Administration Schedule
KW  - Epirubicin
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Middle Aged
KW  - Mitoxantrone
KW  - Neoplasm Recurrence, Local
KW  - epidemiology
KW  - Neoplasms, Second Primary
KW  - classification
KW  - Radiotherapy, Adjuvant
N1  - Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1016/j.ijrobp.2005.10.011
ER  -